- Roche scraps two Ionis-partnered Huntington’s drugs<p>The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal in animal…BioPharma Dive · 17d ago↗ source
- Whistleblower takes on health insurance and FDA commissioner candidatesThis week on "The Readout LOUD" podcast: Why does getting family health insurance through a job cost as much as buying a new car? And who might be the new…STAT · 17d ago↗ source
- ARPA-H bookmarks $160M for custom gene editing treatments. Is it enough?After an infant last year was saved from a deadly disease thanks to a bespoke gene editing therapy that fixed an incredibly rare mutation in his DNA, the US government is hoping ...